Coronary Arteriosclerosis Clinical Trial
Official title:
Dietary Nitrate/Nitrite as Sources of Bioactive Nitric Oxide in Patients With Coronary Artery Disease
Verified date | May 18, 2009 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will determine whether dietary nitrates and nitrites can produce nitric oxide in
the body and dilate blood vessels in patients with coronary artery disease. Nitric oxide is
normally made by endothelial cells that line blood vessels. It plays an important role in
maintaining the normal function of arteries by keeping them open and preventing damage from
substances such as cholesterol in the blood stream. Coronary artery disease is caused by
atherosclerosis (hardening of the arteries or build-up of cholesterol and scar tissue within
the walls of the arteries). Once arteries become clogged, the ability of the endothelium to
produce nitric oxide diminishes considerably and may speed up the disease process, leading to
shortness of breath, chest pain, and an increased risk of heart attack or stroke.
Patients 21 years of age and older with coronary artery disease may be eligible for this
study. Participants will have a medical history and physical examination, electrocardiogram
(recording of the electrical activity of the heart), echocardiogram (ultrasound test of the
heart), treadmill exercise stress test (see below), and will meet with a dietitian. They will
be hospitalized at the NIH Clinical Center on two occasions. For 1 week before each
admission, they will follow a diet prescribed by an NIH nutritionist. The diet before one
admission will be high in nitrates and nitrites, and the diet before the other admission will
be low in nitrates and nitrites. Each admission will last 4 days, during which participants
will undergo the following tests:
- Forearm blood flow study: Small tubes are placed in the artery and vein at the inside of
the elbow of the dominant arm (right- or left-handed) and a small tube is placed in a
vein of the other arm. The tubes are used for infusing saline (salt water) and for
drawing blood samples. A pressure cuff is placed around the upper part of the dominant
arm, and a rubber band device called a strain gauge is also placed around the arm to
measure blood flow. When the cuff is inflated, blood flows into the arm, stretching the
strain gauge at a rate proportional to the flow. Maximum grip-strength of the dominant
arm is measured with a dynamometer. Forearm blood flow is measured and blood samples are
drawn at the following times: 20 minutes after the tubes are placed; during a hand-grip
exercise; and 4 minutes after the exercise is completed.
- Brachial artery reactivity study: This test measures h...
Status | Completed |
Enrollment | 42 |
Est. completion date | |
Est. primary completion date | May 18, 2009 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 22 Years and older |
Eligibility |
- INCLUSION CRITERIA: Adults older than 21 years. Coronary artery disease established by angiography. No myocardial infarction within 1 month. Left ventricular ejection fraction greater than 30%. No congestive heart failure symptoms within 2 months. Subject provides written, informed consent. EXCLUSION CRITERIA: Significant structural heart disease (e.g. hypertrophic or dilated cardiomyopathy, valvular heart disease) as determined by echocardiography. Subject physically unable to perform treadmill exercise due to neurologic or orthopedic conditions. Hypersensitivity to organ nitrates. Insulin-dependant diabetes mellitus. Coumadin therapy (because of vitamin K content of green leafy vegetables). Women of childbearing age unless recent pregnancy test is negative. Lactating women. Unwillingness to adhere to dietary requirements or allergy to necessary components of diets, as determined during interview by the dietician. Surgical or disease-related diminished acid secretion. Significant non-cardiac disease. |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Heart, Lung, and Blood Institute (NHLBI) |
United States,
Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373-6. — View Citation
Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664-6. — View Citation
Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11-17;327(6122):524-6. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Comparison of forearm blood flow during exercise after 3 days of the nitrate-nitrite-enriched diet to forearm blood flow during exercise after 3 days of the nitrate/nitrite-restricted diet. | Measured on day 4 of the nitrite/nitrate enriched and restricted diet | ||
Secondary | Comparison of effects of high versus low nitrate/nitrite diets on exercise forearm blood flow between the two cohorts of patients. | Measured on day 4 of the nitrite/nitrate enriched and restricted diet. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02919124 -
Epicardial Echocardiography of Coronary Anastomoses Using the Echoclip Device
|
N/A | |
Recruiting |
NCT02639962 -
Characteristics of Culprit Lesion and Changes in Plaque Composition. A Dual Energy Cardiac CT Study
|
N/A | |
Completed |
NCT02494557 -
Risk Stratification for Coronary Artery Disease With Type 2 Diabetic Patients
|
N/A | |
Recruiting |
NCT01466452 -
Antiplatelet Effect of Low Doses of Aspirin Taken Every 12 Hours in Patients Undergoing Coronary Artery Bypass Graft and/or Aortic Valve Surgery
|
Phase 2 | |
Completed |
NCT01182428 -
XIENCE V: SPIRIT WOMEN Sub-study
|
Phase 4 | |
Completed |
NCT00368953 -
YUKON Choice Versus TAXUS Liberté in Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT00371891 -
Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS)
|
Phase 4 | |
Completed |
NCT00319449 -
Adding Ezetimibe Tablet to Ongoing Treatment With Atorvastatin in Subjects With High Cholesterol and Multiple Coronary Heart Disease Risk Factors (Study P04060)(COMPLETED)
|
Phase 4 | |
Completed |
NCT00091754 -
Atherosclerosis, Plaque and CVD in Communities
|
||
Completed |
NCT00069797 -
Epidemiology of Coronary Heart Disease in Men Aged 40 and Over
|
N/A | |
Completed |
NCT00037245 -
Androgens and Subclinical Atherosclerosis in Young Women - Ancillary to CARDIA
|
N/A | |
Completed |
NCT00024596 -
Family Heart Study - Subclinical Atherosclerosis Network (FHS-SCAN)
|
N/A | |
Completed |
NCT00006502 -
Myocardial Perfusion, Risk Factors, and Coronary Calcium
|
N/A | |
Completed |
NCT00006407 -
Sex Steroid Hormones and Risk of CHD in Women
|
N/A | |
Withdrawn |
NCT00006497 -
Long-Term Effects of Subclinical CAD on Cardiac Function
|
||
Completed |
NCT00006309 -
Pooling of Cohort Studies on Diet & Coronary Disease
|
N/A | |
Completed |
NCT00005269 -
Family Blood Pressure Program - GENOA
|
||
Completed |
NCT00000508 -
Stanford Coronary Risk Intervention Project (SCRIP)
|
Phase 3 | |
Completed |
NCT00005147 -
Epidemiology of Atherosclerosis
|
N/A | |
Not yet recruiting |
NCT04321473 -
Registry on Left Main Coronary Artery Bifurcation Percutaneous Intervention
|